Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Dec 8, 2025
Reporting period
Not applicable
Filed with the SEC
Dec 8, 2025
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001809519-25-000152
Filed / recorded
Dec 8, 2025, 11:28 PM UTC
Added to OQRO
Oct 7, 2026, 5:51 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
GoodRx Holdings, Inc.
Issuer CIK
1809519
Ticker
GDRX
Reporting person
Romin Nabiey
Relationship
Officer
Officer title
Chief Accounting Officer
Security
Restricted Stock Unit
Table
Derivative (Table II)
Transaction date
Dec 8, 2025
Transaction code
M
Shares / units
10,200
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
30,603
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.